Healthcare provider profile · identity verified

Wendy Denae Crotts, APRN

Nurse Practitioner · MOORELAND, OK · NPI 1427449313

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	375	102
Pantoprazole Sodium	Pantoprazole Sodium	195	52
Atorvastatin Calcium	Atorvastatin Calcium	190	54
Lisinopril	Lisinopril	180	53
Montelukast Sodium	Montelukast Sodium	165	40
Omeprazole	Omeprazole	157	37
Amlodipine Besylate	Amlodipine Besylate	153	44
Gabapentin	Gabapentin	119	28
Losartan Potassium	Losartan Potassium	111	26
Ozempic	Semaglutide	108	21
Albuterol Sulfate Hfa	Albuterol Sulfate	103	42
Diclofenac Sodium	Diclofenac Sodium	94	21
Alprazolam	Alprazolam	92	19
Metoprolol Succinate	Metoprolol Succinate	89	23
Trazodone Hcl	Trazodone Hcl	87	20
Metformin Hcl	Metformin Hcl	86	16
Tamsulosin Hcl	Tamsulosin Hcl	85	24
Pregabalin	Pregabalin	80	12
Furosemide	Furosemide	77	26
Simvastatin	Simvastatin	75	22
Duloxetine Hcl	Duloxetine Hcl	73	16
Mounjaro	Tirzepatide	73	11
Fluconazole	Fluconazole	71	46
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	19
Ropinirole Hcl	Ropinirole Hcl	68	12
Tramadol Hcl	Tramadol Hcl	64	17
Trulicity	Dulaglutide	63	11
Allopurinol	Allopurinol	62	19
Metoprolol Tartrate	Metoprolol Tartrate	62	17
Hydrochlorothiazide	Hydrochlorothiazide	60	23
Clopidogrel	Clopidogrel Bisulfate	58	18
Carvedilol	Carvedilol	57	12
Potassium Chloride	Potassium Chloride	57	19
Sertraline Hcl	Sertraline Hcl	57	14
Pioglitazone Hcl	Pioglitazone Hcl	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	15
Meloxicam	Meloxicam	52	17
Ezetimibe	Ezetimibe	48	13
Acetaminophen-Codeine	Acetaminophen With Codeine	46	15
Escitalopram Oxalate	Escitalopram Oxalate	45	13
Jardiance	Empagliflozin	44	11
Celecoxib	Celecoxib	43	suppressed
Spironolactone	Spironolactone	42	14
Ventolin Hfa	Albuterol Sulfate	41	suppressed
Alendronate Sodium	Alendronate Sodium	40	11
Fluticasone Propionate	Fluticasone Propionate	38	19
Mirtazapine	Mirtazapine	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	12
Glipizide	Glipizide	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Eliquis	Apixaban	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Ondansetron Odt	Ondansetron	34	17
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Estradiol	Estradiol	33	12
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	32	suppressed
Progesterone	Progesterone, Micronized	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	11
Buspirone Hcl	Buspirone Hcl	30	11
Famotidine	Famotidine	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Glimepiride	Glimepiride	27	12
Rosuvastatin Calcium	Rosuvastatin Calcium	27	suppressed
Cephalexin	Cephalexin	26	23
Metformin Hcl Er	Metformin Hcl	26	suppressed
Temazepam	Temazepam	26	suppressed
Atenolol	Atenolol	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Methotrexate	Methotrexate Sodium	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Cimetidine	Cimetidine	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Methylprednisolone	Methylprednisolone	24	23
Naproxen	Naproxen	24	suppressed
Azithromycin	Azithromycin	23	21
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Mupirocin	Mupirocin	19	17
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Clonidine	Clonidine	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nystatin	Nystatin	17	11
Rybelsus	Semaglutide	16	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Leflunomide	Leflunomide	11	suppressed
Prednisone	Prednisone	11	suppressed
Quviviq	Daridorexant Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error